Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Canadian Solar heads into November earnings with nearly 29% of its free float sold short, borrowing costs rising sharply, and a fresh price-target cut from a major Wall Street firm, all at a moment when the stock is already down 12% in a month.
The short position is substantial and has been building. Short interest runs at 28.9% of free float, up 16% over the past month. That monthly climb tells the more important story: positions were added steadily through September as the stock weakened. The borrow market reflects real demand for those shorts. Availability tightened dramatically through late September, hitting a near-zero low of 0.52% on September 29 before loosening somewhat this week to around 15%. The cost to borrow surged 30% in the past week to 2.88%, tracking the tightening cycle, and is up 22% in a month. The ORTEX short score sits at 81.4, near its highest reading of the past several weeks, and ranks in the first percentile of the market. Days-to-cover per FINRA's fortnight data is 9.3 days, meaning unwinding this position would take real time.
Options positioning reinforces the cautious tone. The put/call ratio jumped to 0.37 on Tuesday, more than four standard deviations above its 20-day average of 0.32. That is the highest defensive reading in the past year and a sharp break from the flat range the ratio maintained through all of September and early October. Call open interest still dominates the options book, but this week's shift toward puts is notable given how tight the prior range had been.
The street's posture is essentially defensive hold rather than outright exit. UBS cut its price target this week from $25 to $16, maintaining its Buy rating, a significant trim that acknowledges the deteriorating near-term picture even from a relative bull. Wells Fargo and Mizuho both moved their targets lower after the August earnings, settling around $17, with Equal-Weight and Neutral ratings respectively. GLJ Research remains an outlier sell with a $5.58 target. The mean analyst target across the group is $17.01, against a current price of $11.21. That implies over 50% upside on paper, but the direction of travel on targets has been consistently downward since March, when Roth Capital cut from $30 to $15 and Mizuho moved from $19 to $15. The bull case centres on the E-STORAGE segment and a 6,750 MWh battery shipment target, alongside a 5.0 GW Recurrent Energy development pipeline. The bear case is straightforward: Q4 revenue came in around 4% below prior consensus, battery shipments undershot targets, and the Recurrent Energy segment's gross margin collapsed from 43.9% to 27.7% between quarters. The valuation multiples reflect the mess: price-to-book is 0.22, the company earns no positive net income (PE is negative), and while EV/EBITDA of 7.9 looks undemanding, it has compressed 6% over 30 days as estimates have been cut. EPS momentum over 30 days ranks in the first percentile of the market.
Retail attention is elevated. Wikipedia page views show a z-score of 2.2 against the prior 90 days of traffic, putting Canadian Solar among the more-watched names by non-professional investors right now. That is colour, not a directional signal, but it suggests the stock is on screens beyond just the short community.
Institutional ownership has some interesting texture. BlackRock added 3.7 million shares in the quarter to September 30, lifting its stake to 7.8% of the company, a significant build that runs counter to the short positioning. State Street also added materially, increasing by 932,000 shares in the same period. On the other side, Two Sigma cut its position by 987,000 shares and Morgan Stanley trimmed by 267,000. PAG Castle Holdings, the largest outside block, last filed a 13G/A in July 2025 at 14.1% of class, up from 11.1%. The founder, Xiaohua Qu, remains the largest single holder at just under 21%. All 13D/G positions are as last disclosed around the 5% threshold; holders dropping below that level may not file again.
Earnings history adds context without comfort. The last two prints both saw the stock fall the next day, down 5.3% after the August 2026 report and 3.4% after the prior quarter. The five-day move after each was also negative, at minus 2.5% and minus 5.0% respectively. The next report is scheduled for November 13. Between now and then, the question worth watching is whether availability continues to ease as it did this week, which would signal some short covering, or tightens back toward the late-September lows that preceded a week of stock weakness.
See the live data behind this article on ORTEX.
Open CSIQ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
